Nodus Oncology
Nodus Oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$16m (Public information from Jan 2024)
Company register number SC658917
Macclesfield England (HQ)
Authorizing premium user...